rosiglitazone has been researched along with 10-nitro-oleic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, TE; Berger, JP; Gorczynski, MJ; King, SB; Morrow, CS; Smitherman, PK; Wood, HB | 1 |
| Duncan, SR; Lakshmi, SP; Mallampalli, RK; Reddy, AT; Reddy, RC; Sciurba, FC; Zhang, Y | 1 |
2 other study(ies) available for rosiglitazone and 10-nitro-oleic acid
| Article | Year |
|---|---|
Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by nitroalkene fatty acids: importance of nitration position and degree of unsaturation.
Topics: Alkenes; Cell Line, Tumor; Fatty Acids; Humans; PPAR gamma; Structure-Activity Relationship | 2009 |
Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bronchi; Cells, Cultured; Down-Regulation; Drug Resistance; Gene Knockdown Techniques; Histone Deacetylase 2; Humans; Lung; NF-kappa B; Oleic Acids; Oxidative Stress; PPAR gamma; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Rosiglitazone; Smoking; Thiazolidinediones | 2014 |